Gisele Dion - 22 Jul 2021 Form 3 Insider Report for Cytek BioSciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Gisele Dion
Issuer symbol
CTKB
Transactions as of
22 Jul 2021
Net transactions value
$0
Form type
3
Filing time
22 Jul 2021, 21:07:08 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTKB Stock Option (Right to Buy) 22 Jul 2021 Common Stock 13,333 $4.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 1/24th of the shares subject to the option shall vest monthly over two years from March 31, 2021.

Remarks:

Exhibit 24 - Power of Attorney